Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

Merck & Co took a hit on May 14, 2025, as Citigroup downgraded its rating from "Buy" to "Neutral" and slashed its price ...

Merck (MRK) stock in focus as the FDA approves its anticancer agent Welireg for two rare neuroendocrine tumors, expanding its ...

Merck filed for approval of gefapixant in March 2021 on the strength of a pair of phase 3 trials – COUGH-1 and COUGH-2 – which found that the drug reduced 24-hour cough frequency by 18% and 15 ...

It's a companion shot to Merck's Vaxneuvance (formerly V114), which covers 15 serotypes and was approved by the FDA last year as a rival to Pfizer's Prevnar 13 and newer Prevnar 20 vaccines, which ...

Then they use a variety of thoroughly vetted fundamental value measures and indicators of near-term price appreciation to rank that universe before constructing a 125- to 185-stock portfolio based ...

At times, however, extreme market pressure can force them to cut their dividends, which hurts stock performance. In this month, the strategy also had more exposure to the Yield factor over its peers.

As on 31-03-2025, the company has a total of 1,353.24 Crore shares outstanding.RIL Share Price Today is Rs. 1427.50. On previous day, the RIL Share Price (NSE) closed at Rs. 1436.5, featuring among ...

As on 31-03-2025, the company has a total of 969.67 Crore shares outstanding.NTPC Share Price Today is Rs. 342.65. On previous day, the NTPC Share Price (NSE) closed at Rs. 348.55, featuring among the ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.